Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPRAZOLAM vs CLONAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPRAZOLAM vs CLONAZEPAM: Safety Overview

Metric ALPRAZOLAM CLONAZEPAM
Total FAERS Reports 48,357 39,463
Deaths Reported 16,072 8,488
Death Rate 33.2% 21.5%
Hospitalizations 15,996 12,506
Average Patient Age 48.1 yrs 46.0 yrs
% Female Patients 60.4% 58.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Endo USA, Inc. Advagen Pharma Ltd
Route ORAL ORAL
Marketing Status Prescription Prescription